Retour au classement

Cellebrite DI Ltd. (CLBT)

NEUTRAL
TechnologySoftware - InfrastructureIsrael

Fondamental

68

Prix

$11.50

Capitalisation boursière

$2.84B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilan & Liquidités

Chiffre d'affaires

$496M

12 derniers mois (au 31/03/2026)

Résultat net

$72M

12 derniers mois (au 31/03/2026)

Flux de trésorerie libre

$125M

Capitaux propres totaux

$538M

Passif total

$23M

Ratio de liquidité général

1.62

Couverture des intérêts

-

Dette/EBITDA

0.30

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

Sous-évalué

Juste valeur

$19.57

Prix actuel

$11.50

Marge de sécurité

+41.2%

Fourchette de juste valeur

$12.72 - $26.42

Méthodes d'estimation

Analyst Target:$15.36
DCF:$33.82
PE-based:$5.45
Graham Growth:$11.84
EPV:$1.86
Consensus des analystes:Achat fort (14B / 1H / 0S)
Dernière surprise sur les résultats:-2.57%

Indicateurs de valorisation

Ratio P/E

49.22

ROE

12.4%

Ratio P/B

5.27

P/FCF

22.72

Marge brute

83.0%

ROIC

3.8%

Radar de rentabilité

Value Creation (Economic Moat)

ROIC

3.8%

WACC

10.6%

ROIC − WACC

-6.7 pp

ROIC is below the cost of capital — the company is destroying value for every dollar invested.

Critères d'analyse fondamentale

Réussi (13)

  • Gross Margin 83.0%
  • P/FCF 22.72
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • ROE 15.5%
  • Revenue Growth 5Y 19.5%
  • Analyst Consensus 93% Buy
  • Earnings Surprise avg 6.8%
  • PEG Ratio 0.63
  • Earnings Quality (OCF/NI) 2.01
  • Net Margin Trend 16.5% vs -70.5%

Échoué (6)

  • Price CAGR 0.81%
  • ROIC 3.8%
  • P/B Ratio 5.27
  • CapEx intensity
  • DCF valuation (Overvalued)
  • Piotroski F-Score 2/9

Indisponible (8)

  • EPS data insufficient
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Price below Graham Number
  • Share Dilution (missing shares data)

Score F de Piotroski

2/9

Préoccupations financières sérieuses

score
criteria

Qualité des bénéfices

2.01

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-

Rachat d'actions. Favorable aux actionnaires

Gouvernance

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Latest News

Recent headlines for CLBT, sourced from Markets Gazette.

No recent news for CLBT.